FTC sues key pharmacy benefit administrators in excess of insulin selling prices The company introduced action towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of everyday living-preserving insulin medicines. Sanders swiftly condemned the move in a statement Wednesday, noting https://cristianczwun.ourcodeblog.com/30790364/everything-about-healthcare-news